The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
792
Nimodipine for Cerebral Vasospasm Subarachnoid Hemorrhage
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Nimodipine for Cerebral Vasospasm Subarachnoid Hemorrhage
Cerebral arterial spasm frequently causes ischemic neurological damage after subarachnoid hemorrhage from a ruptured intracranial aneurysm. Nimodipine (Nimotop - Miles), a 1,4-dihydropyridine calcium-entry blocker, was recently approved by the US ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Nimodipine for Cerebral Vasospasm Subarachnoid Hemorrhage
Article code: 792b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.